Jaguar Health
JAGX
1 hedge funds and large institutions have $4.75M invested in Jaguar Health in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
237% more call options, than puts
Call options by funds: $293K | Put options by funds: $87K
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less funds holding
Funds holding: 2 → 1 (-1)
63% less capital invested
Capital invested by funds: $12.8M → $4.75M (-$8.09M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.4M |
| 2 |
Millennium Management
New York
|
-$768K |
| 3 |
JF
Jump Financial
Chicago,
Illinois
|
-$67K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$38K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$32K |
JAGX Hedge Fund Activity: Q4 2021 in Review
1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q4 2021, worth a combined $4.75M — down 63% from $12.8M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of JAGX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, cutting an estimated $2.4M.
- 1 institutional investor held Jaguar Health (JAGX) as of Q4 2021, down from 2 in Q3 2021.
- Funds reported $4.75M of Jaguar Health stock for Q4 2021, down 63% quarter-over-quarter.
- 0 funds opened new Jaguar Health positions in Q4 2021 and 1 closed out, a net change of -1 holder.
- The largest Jaguar Health seller in Q4 2021 was Renaissance Technologies, an estimated $2.4M sold.
Based on aggregated 13F filings for Q4 2021.